Literature DB >> 28629844

Circulating tumor DNA: Solid data from liquid biopsies.

David S Schrump1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28629844      PMCID： PMC6329385          DOI： 10.1016/j.jtcvs.2017.05.059

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  10 in total

1.  [Not Available].

Authors:  P MANDEL; P METAIS
Journal:  C R Seances Soc Biol Fil       Date:  1948-02

2.  Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer.

Authors:  Kezhong Chen; Jingbo Zhang; Tian Guan; Fan Yang; Feng Lou; Wei Chen; Mingyu Zhao; Jay Zhang; Siyi Chen; Jun Wang
Journal:  J Thorac Cardiovasc Surg       Date:  2017-05-24       Impact factor: 5.209

Review 3.  Methylation analyses in liquid biopsy.

Authors:  Delphine Lissa; Ana I Robles
Journal:  Transl Lung Cancer Res       Date:  2016-10

4.  Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.

Authors:  Yu-An Zhang; Xiaotu Ma; Adwait Sathe; Junya Fujimoto; Ignacio Wistuba; Stephen Lam; Yasushi Yatabe; Yi-Wei Wang; Victor Stastny; Boning Gao; Jill E Larsen; Luc Girard; Xiaoyun Liu; Kai Song; Carmen Behrens; Neda Kalhor; Yang Xie; Michael Q Zhang; John D Minna; Adi F Gazdar
Journal:  J Thorac Oncol       Date:  2015-12-25       Impact factor: 15.609

Review 5.  Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer.

Authors:  Kay T Yeung; Soham More; Brian Woodward; Victor Velculescu; Hatim Husain
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

Review 6.  Liquid biopsies come of age: towards implementation of circulating tumour DNA.

Authors:  Jonathan C M Wan; Charles Massie; Javier Garcia-Corbacho; Florent Mouliere; James D Brenton; Carlos Caldas; Simon Pacey; Richard Baird; Nitzan Rosenfeld
Journal:  Nat Rev Cancer       Date:  2017-02-24       Impact factor: 60.716

7.  Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study.

Authors:  L Cabel; F Riva; V Servois; A Livartowski; C Daniel; A Rampanou; O Lantz; E Romano; M Milder; B Buecher; S Piperno-Neumann; V Bernard; S Baulande; I Bieche; J Y Pierga; C Proudhon; F-C Bidard
Journal:  Ann Oncol       Date:  2017-08-01       Impact factor: 32.976

8.  Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages.

Authors:  Meng Yang; Umit Topaloglu; W Jeffrey Petty; Matthew Pagni; Kristie L Foley; Stefan C Grant; Mac Robinson; Rhonda L Bitting; Alexandra Thomas; Angela T Alistar; Rodwige J Desnoyers; Michael Goodman; Carol Albright; Mercedes Porosnicu; Mihaela Vatca; Shadi A Qasem; Barry DeYoung; Ville Kytola; Matti Nykter; Kexin Chen; Edward A Levine; Edgar D Staren; Ralph B D'Agostino; Robin M Petro; William Blackstock; Bayard L Powell; Edward Abraham; Boris Pasche; Wei Zhang
Journal:  J Hematol Oncol       Date:  2017-05-04       Impact factor: 17.388

9.  Circulating tumor DNA detection in lung cancer patients before and after surgery.

Authors:  Nannan Guo; Feng Lou; Yongfu Ma; Jie Li; Bo Yang; Wei Chen; Hua Ye; Jing-Bo Zhang; Ming-Yu Zhao; Wen-Jun Wu; Rong Shi; Lindsey Jones; Katherine S Chen; Xue F Huang; Si-Yi Chen; Yang Liu
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

Review 10.  Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer.

Authors:  Yan Lu; Shulin/Sl Li; Shiguo/Sg Zhu; Yabin/Yb Gong; Jun/J Shi; Ling/L Xu
Journal:  Biol Proced Online       Date:  2017-03-17       Impact factor: 3.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.